Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-03 Sale | 2025-03-03 8:46 pm | HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director | 5,000 | $58.69 | $293,458 | 33,611 (Direct) | View |
| 2025-02-25 Sale | 2025-02-27 6:32 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 21,697 | $58.1 | $1,260,681 | 173,756 (Direct) | View |
| 2025-02-03 Sale | 2025-02-04 6:07 pm | HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director | 5,000 | $56.3 | $281,517 | 38,611 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 4:14 pm | HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director | 10,000 | $50.01 | $500,060 | 43,611 (Direct) | View |
| 2024-10-15 Sale | 2024-10-16 6:53 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $53.5 | $1,070,059 | 243,324 (Direct) | View |
| 2024-10-08 Sale | 2024-10-09 5:39 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 20,000 | $53.29 | $1,065,743 | 686,744 (Direct) | View |
| 2024-09-24 Sale | 2024-09-26 6:06 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $56.88 | $1,706,440 | 766,744 (Direct) | View |
| 2024-09-17 Sale | 2024-09-18 6:49 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $62.45 | $1,249,096 | 207,478 (Direct) | View |
| 2024-09-10 Sale | 2024-09-12 5:56 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $59.13 | $1,773,790 | 856,744 (Direct) | View |
| 2024-08-20 Sale | 2024-08-21 6:03 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $61.4 | $1,228,020 | 241,898 (Direct) | View |
| 2024-08-13 Sale | 2024-08-15 4:59 pm | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $57.15 | $1,714,451 | 946,744 (Direct) | View |
| 2024-08-12 Sale | 2024-08-14 4:57 pm | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 29,881 | $56.53 | $1,689,294 | 69,874 (Direct) | View |
| 2024-07-23 Sale | 2024-07-24 5:48 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $55 | $1,100,023 | 221,752 (Direct) | View |
| 2024-07-22 Sale | 2024-07-23 4:37 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $53.93 | $269,662 | 15,480 (Direct) | View |
| 2024-06-26 Sale | 2024-06-28 4:06 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $51.93 | $1,557,940 | 60,480 (Direct) | View |
| 2024-06-18 Sale | 2024-06-20 4:17 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $49.43 | $494,260 | 179,891 (Direct) | View |
| 2024-06-11 Sale | 2024-06-13 4:15 pm | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 20,000 | $50.31 | $1,006,300 | 99,755 (Direct) | View |
| 2024-05-21 Sale | 2024-05-22 5:24 pm | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $45.27 | $905,480 | 221,606 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-23 Exercise | 2025-02-24 5:11 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 4,747 | $0 | 209,691 (Direct) | View |
| 2025-02-23 Tax Withholding | 2025-02-24 5:11 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2,410 | $57.75 | 209,691 (Direct) | View |
| 2025-02-23 Exercise | 2025-02-24 5:07 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 7,012 | $0 | 49,522 (Direct) | View |
| 2025-02-23 Tax Withholding | 2025-02-24 5:07 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 3,775 | $57.75 | 49,522 (Direct) | View |
| 2025-02-23 Exercise | 2025-02-24 5:04 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 6,688 | $0 | 51,963 (Direct) | View |
| 2025-02-23 Tax Withholding | 2025-02-24 5:04 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 3,601 | $57.75 | 51,963 (Direct) | View |
| 2025-02-23 Exercise | 2025-02-24 5:01 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 22,436 | $0 | 801,027 (Direct) | View |
| 2025-02-23 Tax Withholding | 2025-02-24 5:01 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 12,081 | $57.75 | 801,027 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-21 6:52 pm | 2026-02-20 2035-02-20 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 23,132 | $0 | 23,132 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-21 6:50 pm | 2026-02-20 2035-02-20 | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 43,930 | $0 | 43,930 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-21 6:49 pm | 2026-02-20 2035-02-20 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 43,930 | $0 | 43,930 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-21 6:47 pm | 2026-02-20 2035-02-20 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 138,065 | $0 | 138,065 (Direct) | View |
| 2025-02-15 Exercise | 2025-02-18 6:42 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 34,652 | $0 | 207,754 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-18 6:42 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 15,292 | $58.29 | 207,754 (Direct) | View |
| 2025-02-16 Exercise | 2025-02-18 6:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 22,205 | $0 | 34,844 (Direct) | View |
| 2025-02-16 Tax Withholding | 2025-02-18 6:41 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 11,955 | $58.29 | 34,844 (Direct) | View |
| 2025-02-15 Exercise | 2025-02-18 6:39 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 29,085 | $0 | 44,564 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-18 6:39 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 15,752 | $58.29 | 44,564 (Direct) | View |
| 2025-02-15 Exercise | 2025-02-18 6:37 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 122,786 | $0 | 778,122 (Direct) | View |
| 2025-02-15 Tax Withholding | 2025-02-18 6:37 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 66,166 | $58.29 | 778,122 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 6:12 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 36,702 | $0 | 52,701 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 6:11 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 48,067 | $0 | 62,093 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 6:09 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 46,868 | $0 | 61,190 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 6:08 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 164,380 | $0 | 222,589 (Direct) | View |
| 2025-01-03 Tax Withholding | 2025-01-06 5:12 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 4,289 | $47.74 | 22,613 (Direct) | View |
| 2025-01-03 Exercise | 2025-01-06 5:12 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 7,611 | $0 | 22,613 (Direct) | View |
| 2024-11-29 Gift | 2024-12-03 4:05 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director | 10,470 | $0 | 183,035 (Direct) | View |
| 2024-11-29 Gift | 2024-12-03 4:04 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 10,000 | $0 | 666,744 (Direct) | View |
| 2024-10-15 Exercise | 2024-10-16 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,509 | $16.65 | 243,324 (Direct) | View |
| 2024-10-15 Exercise | 2024-10-16 6:53 pm | N/A 2029-02-12 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 243,324 (Direct) | View |
| 2024-10-15 Exercise | 2024-10-16 6:53 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 14,491 | $19.98 | 243,324 (Direct) | View |
| 2024-10-08 Exercise | 2024-10-09 5:39 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 20,000 | $13.87 | 686,744 (Direct) | View |
| 2024-09-24 Exercise | 2024-09-26 6:06 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 766,744 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-18 6:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $16.65 | 207,478 (Direct) | View |
| 2024-09-17 Exercise | 2024-09-18 6:49 pm | N/A 2029-02-12 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 207,478 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-12 5:56 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 856,744 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-27 7:49 pm | N/A 2028-02-14 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,580 | $0 | 173,756 (Direct) | View |
| 2024-08-27 Exercise | 2024-08-27 7:49 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 5,580 | $18.41 | 173,756 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-21 6:03 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $16.65 | 241,898 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-21 6:03 pm | N/A 2029-02-12 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 241,898 (Direct) | View |
| 2024-08-13 Exercise | 2024-08-15 4:59 pm | N/A 2025-02-06 | HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO | 30,000 | $13.87 | 946,744 (Direct) | View |
| 2024-07-24 Exercise | 2024-07-24 5:48 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 8,285 | $16.65 | 221,752 (Direct) | View |
| 2024-07-23 Exercise | 2024-07-24 5:48 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 221,752 (Direct) | View |
| 2024-07-23 Exercise | 2024-07-24 5:48 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 11,715 | $8.11 | 221,752 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 4:37 pm | N/A 2025-07-01 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $0 | 15,480 (Direct) | View |
| 2024-07-22 Exercise | 2024-07-23 4:37 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 5,000 | $22.5 | 15,480 (Direct) | View |
| 2024-06-26 Exercise | 2024-06-28 4:06 pm | N/A 2025-07-01 | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $0 | 60,480 (Direct) | View |
| 2024-06-26 Exercise | 2024-06-28 4:06 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER | 30,000 | $22.5 | 60,480 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-20 4:17 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $0 | 179,891 (Direct) | View |
| 2024-06-18 Exercise | 2024-06-20 4:17 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 10,000 | $8.11 | 179,891 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:17 pm | 2025-06-12 N/A | HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | 20,137 | $0 | 20,137 (Direct) | View |
| 2024-05-21 Exercise | 2024-05-22 5:24 pm | N/A 2026-02-03 | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $0 | 221,606 (Direct) | View |
| 2024-05-21 Exercise | 2024-05-22 5:24 pm | N/A N/A | HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 20,000 | $8.11 | 221,606 (Direct) | View |
| 2024-04-25 Option Award | 2024-04-29 6:11 pm | N/A 2034-04-25 | HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director | 15,305 | $0 | 128,559 (Direct) | View |